Clinical Trials Logo
  1. Home
  2. Varicose Veins
  3. NCT01203397
  4. Details
NCT01203397 Clinical Trial

Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment

VARICOSE VEINS Clinical Trial

Official title:
PHASE III OF SAFETY AND EFFICACY STUDY OF TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G IN THE SUPERFICIAL VARICOSE VEINS TREATMENT

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT01203397
Other study ID # MPSEMS0110
Secondary ID
Status Withdrawn
Phase Phase 3
First received
Last updated
Start date September 2014
Est. completion date February 2015

Study information
Verified date February 2021
Source EMS
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate in the treatment of superficial varicose veins

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date February 2015
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Patients must be able to understand the study procedures, agree to participate, and give written consent. - Patients must be able to follow the study medication regimen. - Patients with inflammatory process in superficial veins for more than 72 hours. - Presence of symmetric lesions to compare one side to the other. Exclusion Criteria: - Pregnancy or risk of pregnancy. - Lactation. - Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study - Any alteration at other deep veins. - History of atopy or allergic diseases. - History of allergy to any component of the formulations. - Other conditions considered by the investigator as reasonable for non-eligibility.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• TOPIC MUCOPOLYSACCHARIDE POLYSULFATE 5MG/G
APLIED 4 TIMES/DAY AT LESION

Locations
Country Name City State
Brazil Medcin Instituto Da Pele Osasco SÃO Paulo

Sponsors (1)
Lead Sponsor Collaborator
EMS

Country where clinical trial is conducted

Brazil, 

Outcome
Type Measure Description Time frame Safety issue
Primary Efficacy - Symptoms reduction The primary outcome measure will be evaluated for: Lesion area reduction, reduction of symptoms time and edema. Evaluation time: 3 - 7 - 10 and 15 days
Secondary Efficacy - patient evaluation The secondary outcome measure will be measured by subjective opinion (daily register. 15 days
See also
  Status Clinical Trial Phase
Completed NCT02441881 - Trial of Radiofrequency Thermo-ablation Treatments of Great Saphenous Varicose Veins (3-RF Study) N/A
Completed NCT03283800 - Copper Impact on Venous Insufficiency and Lipodermatosclerosis N/A
Recruiting NCT02676908 - Optimum Duration of Compression Stockings After Endovenous Varicose Vein Surgery N/A
Withdrawn NCT01426035 - Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate Cream In The Superficial Varicose Veins Treatment Phase 3
Recruiting NCT02054325 - Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins Phase 4
Withdrawn NCT03601572 - Hypnoanalgesia in Surgical and Endovenous Treatment of Varicosis
Completed NCT04933591 - Impact of Treatment With VENARUS® on the Level of Monocyte Chemoattractant Protein 1 in Varicose Veins Blood N/A
Active, not recruiting NCT02397226 - Lower Limb Venous Insufficiency and the Effect of Radiofrequency Treatment Versus Open Surgery N/A
Withdrawn NCT02936271 - Efficacy of Vasculera in Prevention on Post-op Pain and Edema Following Lower Extremity Venous Treatment in the Outpatient Setting N/A
Terminated NCT02557542 - Pilot RCT Evaluating a One Stop Vein Clinic N/A
Completed NCT00758420 - Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ Incompetence Phase 2/Phase 3
Active, not recruiting NCT00841178 - Endovenous Laser Therapy (EVLT) for Sapheno-Popliteal Incompetence and Short Saphenous Vein (SSV) Reflux: A RCT N/A
Not yet recruiting NCT05508581 - Microwaves Ablation of Varicose Veins N/A
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Active, not recruiting NCT04339075 - Registry to Investigate the Efficacy and Safety of VenaBlock VeIn SEaling System for VaRicose Veins in SingApore
Completed NCT03392753 - Mechanochemical Ablation Compared to Cyanoacrylate Adhesive N/A
Recruiting NCT04146168 - Lake Washington Vascular VenaSeal™ Post-Market Evaluation
Recruiting NCT02304146 - Long-term Ultrasound Guided Foam Sclerotherapy Versus Classical Surgical Stripping Study N/A
Completed NCT01231373 - Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence Phase 3
Completed NCT01200199 - Validity of Electronic Diary for Monitoring Varicose Veins Symptoms